Ramat Gan, Israel

David Altman

This inventor holds 1 USPTO granted patent. Top assignee: Bar-Ilan University. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Altman. Retrieved from https://idiyas.com/inventor/david-altman-usl6gnrc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Altman: Innovator in Anti-Allergic Extracts

Introduction

David Altman is a notable inventor based in Ramat Gan, Israel. He has made significant contributions to the field of allergy treatment through his innovative research and development. His work focuses on creating effective solutions for individuals suffering from allergies.

Latest Patents

David Altman holds a patent for an anti-allergic extract. The present invention describes a novel material that is extractable from plants of the order Malvales, demonstrating anti-allergic activity. This breakthrough has the potential to improve the quality of life for many allergy sufferers.

Career Highlights

David Altman is affiliated with Bar-Ilan University, where he conducts his research and development. His academic background and expertise have positioned him as a key figure in the study of allergy treatments. He has successfully translated his research into practical applications that benefit society.

Collaborations

David has collaborated with esteemed colleagues such as Shlomo Grossman and Rina Reznik. These partnerships have fostered a productive research environment, leading to advancements in the field of allergy treatment.

Conclusion

David Altman's contributions to the field of anti-allergic extracts highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire future research and development in allergy treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…